Leqvio is a new medication that has been approved by the FDA for the treatment of high cholesterol. It belongs to a class of drugs known as PCSK9 inhibitors, which work by blocking a protein in the liver that reduces the liver’s ability to remove LDL cholesterol from the blood.

High cholesterol is a major risk factor for heart disease and stroke, so it is important to effectively manage cholesterol levels to reduce the risk of these serious health conditions. Leqvio has been shown to significantly lower LDL cholesterol levels in clinical trials, making it a promising option for patients who have not been able to achieve their cholesterol goals with diet and exercise alone.

As with any medication, it is important to discuss the potential benefits and risks of Leqvio with your healthcare provider. Common side effects of Leqvio may include injection site reactions, flu-like symptoms, and muscle pain. It is also important to monitor liver function while taking Leqvio, as some patients may experience liver problems while on the medication.

Overall, Leqvio is a valuable addition to the treatment options available for high cholesterol and may be a good choice for patients who need additional help in managing their cholesterol levels. If you have questions about Leqvio or would like to learn more about whether it is the right choice for you, please consult with your healthcare provider.